Is there any doubt of that. The Street is a tool used by hedge shorts, so they will do anything to push down the price. However the INO PII result is so solid there is little possibility for them to come out a viable argument against it. Just see how feeble AF's argument using the 3% patients drop out to try to reinterpret the solid result to show his lack of scientific background and desperation to find fault. No problem for us longs with understanding of the science and the competence of Dr. Kim. Games will continue to be played. I am actually watching closely and ready to add to my position. INO is a game changer in treating diseases with its long term prospect simply staggering!
Good. Cramer is always a reliable contrary indicator. Am glad he will make negative remarks on this co.
His biotech writer, AF, bashed INO recently and it came out with result opposite to this guy's prediction yesterday and see how INO shot up. You can make serious money doing the opposite of what they say!
While Yellen's testimony related to the biotech and social media stocks being "over-stretched" led to the recent downward pressures, I can't put all the blame on her. If you recalled we had an earlier statement in late Feb by the New York Fed chair stating the same thing about biotech and the whole sector came down with a majority came back up until Yellen's statement last week. However SGMO never came back up since the recent high of $22. Why? All the insiders selling shares monthly is why. If the insiders have not shown confidence in their own co, why should investors buy the shares. It has become quite ridiculous for the management including the CEO to sell monthly, while he has a salary of over $1 million. What kind of lifestyle he wants to have, seriously. He is making more money than at least 95% of investors in the co and he continues to sell shares! Have been long for over a couple years and not good to see recent shares bought under water big time. In the meantime what do the management have for show? JPM is probably getting eggs on its face selling the secondary shares at over $20 to its shareholders at over 40% of its current price.
SGMO's partner, Shire, is being bought, so any progress on the development with Shire will be either halted or slowed down. I won't be surprised our management will continue to do their monthly selling at whatever the cost. Anyway these all are option shares, so they make a profit at any price.
I don't think Chow's point is totally objective in that he was tooting the superior approach of his team without detailing why the negative outcome from electroporation. It sounds like an opinion rather than a result from empirical comparison of the two types. In any case, it is a moot point at this stage since we'll learn very soon the INO PII result. Either we are successful or not. Chow's presentation will have no impact after that. Factual result will speak for itself. I believe in Dr. Kim and his approach. Don't get distracted by noise.
Comparing SYN with VICL is ridiculous in itself. If one can't see the difference in the respective connections with other cos, the quality of management and pipeline and those investing in the cos, one deserves to lose money ultimately as a short. We'll see by the end of the year. We have all put in our bets based on our beliefs and DD, the result will speak for itself. In the meantime, shorts will continue to pay a hefty fee shorting SYN at this ridiculously low price. Smart shorts, Ha!
In the last CC when Trimesta result was discussed, CEO Riley mentioned numerous times that a few pharmas were interested in its results, particularly related to the improved cognitive functioning by those taking the drug. He further mentioned later that UCLA may do a trial specifically for the cognitive assessment. We heard nothing since and the share price has moved downward. I still believe there might be interest in Trimesta and if this is the case, it may explain the silence on that development. There are simply too many possibilities in its pipeline and anyone, if developed successfully, will be a blockbuster. The share price is so ridiculous low with practically NO value put into this co. Let's face it, its connection with XON alone is worth the share price, not to mention R.Kirk is the largest shareholder. Patience should pay off big time with a horizon of may be a couple years. If any announcement related to Trimesta's partnership with a big pharma, it will be an instant double!
Cramer just bashed DDD in CNBC program and touted SSYS. Must have shorted DDD and longed SSYS. He is certainly a contrary indicator! We are UP, despite his efforts along with his short friends.
ed, I took a small position upon reading the "bs" SA article as you referred to. I believe the high volume following the publication of the article might reflect readers, like me, who believe this co is very under-valued as the author had said. After all, who can resist buying a co with cash almost equaling to its share price without debt. On top of that one even receives a nice dividend to boot! You may know the co a lot better than those of us new comers and have a less than positive view of the CEO who is the largest shareholder, but the fact remains insiders own over 25% of shares and institutions own over 60% of shares with some very reputable names among them. So what not to like this co at this ridiculously low price? The CEO who obviously you hold contempt for is over 70 and conceivably may decide to retire and sell the co. Of course this is pure speculation, but I do believe this co is totally under-valued and at the present price up to $12 is among those stocks for long term investors to simply buy and put it away for bigger gain. In the meantime get paid for waiting. JMHO.
News, if any, will be released at 4:00 am Monday morning. This has been the pattern. I still believe the news will be released in full, not piecemeal for maximum impact without having sleazy people like AF to "interpret" (distort) the data. Dr. Kim knows how to deal with such people now.
First, the offering was reduced with its IPO price reduced as well. With two large biotech firms, CELG and GILD and best of breed in the space, having partnership with the co, it seems to be a reasonable speculative investment by small investors with risk capital. It was a good sign to have moved up in share price on the first day of trading. What is left is for possible good news in a month after the quiet period. I picked up some shares and am willing to pick up more if price drops.
Worried shorties come in droves. Will experience further financial pain tomorrow and beyond. Delightful sight to watch for the rest of July!
I totally agree with you about Dr. Kim's disgust of such manipulations, particularly by AF with a forum to attack co randomly without base. In this case he basically accused Dr. Kim of being a #$%$ with knowledge of failure without disclosing, but to "prepare" investors for the failure. This is a very serious accusation of Dr. Kim's integrity and honesty. AF simply projects his own character onto others. If you recall, in Dr.Kim's rebuttal the next day, he used word like "malicious" to describe the intent/nature of AF's article. I believe he will drop a bomb with good news and will take legal action, after the PII result with positive findings as contrary to AF's accusation. I just don't think AF can get away this time with his unfound claims. I love to see SEC takes action against this type of practice.
There is always the possibility for another partnership signed and announced. INO seems likes to make announcement at $;00 in the morning. Must be a hard working bunch. I like it. Shorts continue to be burned after market.
Last Friday was the day, not tomorrow. No need to find reasons for its price movement, either up or down. If there is news on a partnership, it will double for sure. Its connection with XON can be very helpful at the same time makes partnership process a bit more complicated because XON's role in the process as well. May be this is the reason it takes so much time to finalize it. It will get done with the question "when".
It is so easy for guys like you to use such catch words as "Pump and Dump", particularly for those shorting the stock. When the SA article came out on a weekend, the stock was at $7.85 and starting the run on Monday, it went up over $11 within days, a 40% rise. You don't think many started to take profit today with the market uncertainty? The fact it still closed at $8.9 at 13% higher before the run and the after market price went up another 3% isn't shabby, certainly not a pump and dump scheme you seemed to be used to get involved. As the author said in the SA article, this is a multi-bagger stock with positive earnings next quarter and onward. This is a very rare small stock to be bought for tremendous gain.
Good news just came in after market today! Will be back over $2 tomorrow. The next piece of news will be the dismissal of the delisting reasons and the share will go to $2.5. Imagine what next news of label extension approval in EU will do for the share price?
These short bottom feeders probably won't cover and thus suffer the most financial ruin following AF who simply did what he had been told by hedge funds to knock down the price for them to buy in. Ill educated bottom feeders won't know that, thus suffer from their stupidity. In four weeks we'll see the carnage.
Shorts already started covering after market close Friday. That was why it was up 9 cents post market upon the gain already in the regular session. I believe we'll start moving upward Monday morning leading all the way to the presentation in the afternoon and continue on. Will be an exciting few weeks waiting for the data release which will totally destroyed AF's credibility which he doesn't have much left anyway.
Sentiment: Strong Buy